Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * Disallow: |
Title | Ergon Pharma – Advanced |
Description | Utilizing Advanced Technologies to Develop Innovative HOME TECHNOLOGY PIPELINE COLLABORATIONS PUBLICATIONS NEWS ABOUT US Loading... Utilizing Advanced Technologies to Develop Innovative Therapies Home firemys |
Keywords | N/A |
WebSite | ergonpharma.com |
Host IP | 198.71.233.184 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2022-07-07 17:02:56
ergonpharma.com has Semrush global rank of 0. ergonpharma.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. ergonpharma.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.184. According to SiteAdvisor, ergonpharma.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ergonpharma.com. | A | 599 | IP: 198.71.233.184 |
ergonpharma.com. | NS | 3600 | NS Record: ns31.domaincontrol.com. |
ergonpharma.com. | NS | 3600 | NS Record: ns32.domaincontrol.com. |
ergonpharma.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
ergonpharma.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
ergonpharma.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
ergonpharma.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
ergonpharma.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
ergonpharma.com. | TXT | 3600 | TXT Record: google-site-verification=PpXsiuCnJ0aRau5QCnPNNp-QZJtWr9OXMXYsO7cp4Pc |
ergonpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:dc-aa8e722993._spfm.ergonpharma.com ~all |
HOME TECHNOLOGY PIPELINE COLLABORATIONS PUBLICATIONS NEWS ABOUT US Loading... Utilizing Advanced Technologies to Develop Innovative Therapies Home firemyst 2017-08-24T18:49:19+00:00 Advanced Technologies We employ advanced technologies as well as old-fashioned hypothesis-based trial-and-error techniques to determine the role of a protein target in promoting and sustaining a disease state. Once a novel target has been identified we utilize our medicinal chemistry expertise to design small molecule inhibitors Contact Us Ergon Pharmaceuticals © Copyright 2012 - | Ergon Pharmaceuticals Washington DC All Rights Reserved | Facebook Twitter |
HTTP/1.1 200 OK Accept-Ranges: bytes Age: 54915 Content-Length: 46914 Content-Type: text/html; charset=UTF-8 Date: Fri, 29 Oct 2021 08:27:50 GMT Vary: Accept-Encoding, User-Agent X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Content-Type-Options: nosniff X-Pingback: http://ergonpharma.com/xmlrpc.php X-Tec-Api-Origin: http://ergonpharma.com X-Tec-Api-Root: http://ergonpharma.com/wp-json/tribe/events/v1/ X-Tec-Api-Version: v1 X-Xss-Protection: 1; mode=block |
Domain Name: ERGONPHARMA.COM Registry Domain ID: 2144558839_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.aitdomains.com Registrar URL: http://www.ait.com Updated Date: 2019-06-25T14:16:50Z Creation Date: 2017-07-18T19:16:23Z Registry Expiry Date: 2022-07-18T19:16:23Z Registrar: Advanced Internet Technologies, Inc. (AIT) Registrar IANA ID: 57 Registrar Abuse Contact Email: abuse@ait.com Registrar Abuse Contact Phone: 1-877-209-5184 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS31.DOMAINCONTROL.COM Name Server: NS32.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T11:30:35Z <<< |